These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12215379)

  • 1. Human thrombocytes are able to induce a myocardial dysfunction in the ischemic and reperfused guinea pig heart mediated by free radicals-role of the GPIIb/IIIa-blocker tirofiban.
    Seligmann C; Simsek Y; Schimmer M; Leitsch T; Bock A; Schultheiss HP
    Life Sci; 2002 Sep; 71(19):2319-29. PubMed ID: 12215379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A myocardial ischemia- and reperfusion-induced injury is mediated by reactive oxygen species released from blood platelets.
    Seligmann C; Prechtl G; Kusus-Seligmann M; Daniel WG
    Platelets; 2013; 24(1):37-43. PubMed ID: 22372536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thrombocyte-induced myocardial dysfunction in the ischemic and reperfused guinea pig heart is mediated by reactive oxygen species.
    Seligmann C; Schimmer M; Leitsch T; Bock A; Simsek Y; Tschöpe C; Schultheiss HP
    Free Radic Biol Med; 2000 Dec; 29(12):1244-51. PubMed ID: 11118814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMN/platelets coinfused in guinea pig hearts Exposed to low-flow ischemia have no additive cardiodepressive effect.
    Seligmann C; Leitsch T; Kusus M; Bock A; Schimmer M; Simsek Y; Daniel WG
    J Vasc Res; 2003; 40(6):501-8. PubMed ID: 14631104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear granulocytes induce myocardial dysfunction during ischemia and in later reperfusion of hearts exposed to low-flow ischemia.
    Seligmann C; Bock A; Leitsch T; Schimmer M; Simsek Y; Schultheiss HP
    J Leukoc Biol; 2001 May; 69(5):727-31. PubMed ID: 11358980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts.
    Heindl B; Zahler S; Welsch U; Becker BF
    Cardiovasc Res; 1998 May; 38(2):383-94. PubMed ID: 9709399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
    Beresewicz A; Czarnowska E; Maczewski M
    Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury.
    Kupatt C; Habazettl H; Hanusch P; Wichels R; Hahnel D; Becker BF; Boekstegers P
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2226-32. PubMed ID: 11031208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pigs: role of glycoprotein IIB/IIIA receptors.
    Molero L; Farré J; García-Mendez A; Jiménez Mateos-Caceres P; Carrasco Martín C; Millás I; Navarro F; Córdoba M; Casado S; López-Farré A
    Cardiovasc Res; 2003 Jan; 57(1):109-18. PubMed ID: 12504820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion.
    Kupatt C; Wichels R; Horstkotte J; Krombach F; Habazettl H; Boekstegers P
    J Leukoc Biol; 2002 Sep; 72(3):455-61. PubMed ID: 12223512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts.
    Heindl B; Conzen PF; Becker BF
    Basic Res Cardiol; 1999 Apr; 94(2):102-11. PubMed ID: 10326658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
    Goto S; Tamura N; Ishida H
    J Am Coll Cardiol; 2004 Jul; 44(2):316-23. PubMed ID: 15261925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
    Rukshin V; Azarbal B; Finkelstein A; Shah PK; Cercek B; Tsang V; Kaul S
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):615-24. PubMed ID: 12658064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine endogenously released during early reperfusion mitigates postischemic myocardial dysfunction by inhibiting platelet adhesion.
    Seligmann C; Kupatt C; Becker BF; Zahler S; Beblo S
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):156-63. PubMed ID: 9676736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
    Rao AK; Sun L; Hiramatsu Y; Gorman JH; Edmunds LH
    Thromb Haemost; 1999 Jul; 82(1):140-4. PubMed ID: 10456468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glycoprotein IIb/IIIa platelet receptor blocker tirofiban, but not heparin, counteracts platelet aggregation in unstable angina pectoris.
    Mattsson E; Martinsson A; Nyqvist O; Rasmanis G; Sylvén C; Karlberg KE
    Am J Cardiol; 1997 Oct; 80(7):938-40. PubMed ID: 9382012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.